痰热清注射液雾化吸入治疗发作期小儿哮喘的临床疗效观察  

Clinical Observation of Tanreqing Injection (by Aerosol Inhalation) for Acute Athma Attack in Children

作　　者：纪莎[1] 胡雯玲[1] 李希[2] 

机构地区：[1]福建中医学院附属第二人民医院药剂科,福州市350001 [2]福建中医学院附属第二人民医院呼吸内科,福州市350001

出　　处：《中国药房》2008年第33期2617-2618,共2页China Pharmacy

摘　　要：目的:观察痰热清注射液雾化吸入治疗发作期小儿哮喘的临床疗效。方法:将发作期哮喘患儿60例随机分为2组:对照组29例,在常规治疗的基础上雾化吸入布地奈德雾化混悬液;治疗组31例,在常规治疗的基础上雾化吸入痰热清注射液。疗程均为2d。结果:治疗组总有效率为83.87%,与对照组(79.31%)比较无显著性差异;2组治疗前、后肺功能变化比较无显著性差异。结论:痰热清注射液雾化吸入治疗发作期小儿哮喘的疗效与布地奈德疗效相当。OBJECTIVE：To observe the clinical efficacy of Tanreqing injection （by aerosol inhalation） in the treatment of children with acute asthma attack .METHODS：A total of 60 children with acute asthma attack were randomly divided into two groups：29 in the control group were assigned to receive routine therapy plus Budesonide suspl. （by aerosol inhalation）, and 31 in the trial group to receive routine therapy plus Tanreqing injection（by aerosol inhalation）. The course of treatment lasted 2 days for both groups.RESULTS： There were no significant differences between the trial group and the control group in total effective rate（83.87% vs. 79.31% ）. There were no significant differences between the two groups in lung function before and after treatmeat .CONCLUSION： Inhalation of Tanreqing injection and Budesonide showed equivalent efficacy for the treatment of children with acute asthma attack.

关 键 词：发作期小儿哮喘 痰热清注射液 雾化吸入 临床疗效 

分 类 号：R283.611[医药卫生—中药学] R985[医药卫生—中医学]